Ellipta is part of GlaxoSmithKline's trade names of several inhalable asthma and chronic obstructive airway disease (COPD) combination medications that make use of the same type of inhaler:
- Fluticasone furoate (Arnuity Ellipta, Relvar Ellipta)
- Fluticasone furoate/vilanterol (Breo Ellipta, Relvar Ellipta)
- Fluticasone furoate/umeclidinium bromide/vilanterol (Trelegy Ellipta)
- Umeclidinium bromide (Incruse Ellipta)
- Umeclidinium bromide/vilanterol (Anoro Ellipta)
Further reading
edit- Grant AC, Walker R, Hamilton M, Garrill K (2015). "The ELLIPTA Dry Powder Inhaler: Design, Functionality, In Vitro Dosing Performance and Critical Task Compliance by Patients and Caregivers". J Aerosol Med Pulm Drug Deliv. 28 (6): 474–85. doi:10.1089/jamp.2015.1223. PMC 4685506. PMID 26372466.
This article includes a list of related items that share the same name (or similar names).
If an internal link incorrectly led you here, you may wish to change the link to point directly to the intended article.
If an internal link incorrectly led you here, you may wish to change the link to point directly to the intended article.